Stem Cell Research Ordinance (SCRO)
English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.
Art. 28 Purpose of the register
The register specified in Article 18 StRA is intended in particular: a. to enable embryonic stem cells to be passed on for research projects carried out in Switzerland, as specified in Article 9 paragraph 1 letter c StRA; b. to permit assessment of whether embryonic stem cells suitable for a research project are available in Switzerland; c. to provide an overview of ongoing and completed research projects in Switzerland.
Art. 29 Content of the register
1 Any person who derives embryonic stem cells, carries out a research project aimed at improving derivation methods, or involving embryonic stem cells, or imports embryonic stem cells must submit the following information to the FOPH: a. a description of the project in which the stem cells are derived or used, including the following details: 1. title of the project, 2. objective of the project, 3. name and address of the licence holder, 4. starting date and expected duration of the project; b. a characterisation of the embryonic stem cells derived or used in the project, and of the stem cell lines used; stem cell lines are pluripotent cells derived from cells of an early embryo, which can be cultured in vitro and reproduced over generations, exhibiting a stable genotype and phenotype. 2 The FOPH shall include in the register the information required by paragraph 1 letter a when a licence is granted under Articles 5, 8 or 13, or when a notification is received under Article 20. 3 It sh
Para. 1 let. a let. 3 — Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 325).